MS1819-SD

DRUG2 trials

Sponsors

AzurRx SAS

Conditions

Chronic PancreatitisCystic FibrosisCystic Fibrosis Gastrointestinal DiseaseCystic Fibrosis of PancreasDistal Pancreatectomy

Phase 2

A Phase IIa Study With Escalating Dose of MS1819-SD

CompletedNCT03481803

AzurRx SASChronic Pancreatitis, Distal Pancreatectomy

Start: 2017-01-27End: 2018-06-29Updated: 2018-09-28

Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs

CompletedNCT04302662

AzurRx SASCystic Fibrosis, Cystic Fibrosis Gastrointestinal Disease, Cystic Fibrosis of Pancreas

Start: 2019-06-27End: 2021-06-03Updated: 2021-08-19